Patent application number | Description | Published |
20080214673 | Acetylene Derivatives - The invention provides compounds of formula (I) | 09-04-2008 |
20090005363 | Organic Compounds - The present invention relates to novel nicotinic acid derivatives, of formula (I) | 01-01-2009 |
20090105266 | Organic compounds - The present invention relates to novel benzimidazole derivatives, their preparation, their use as pharmaceuticals and pharmaceutical compositions containing them, wherein the compounds have the formula (I): | 04-23-2009 |
20090286827 | NOVEL BI-ARYL AMINES - The present invention relates to novel bi-aryl amines of formula (I) and to pharmaceutically acceptable prodrugs, salts, solvates, hydrates, and N-oxides thereof and to pharmaceutical compositions comprising them, methods of their use, and methods of their preparation. | 11-19-2009 |
20100022500 | Macrocyclic Lactams and Pharmaceutical Use Thereof - The present invention relates to novel macrocyclic compounds of the formula | 01-28-2010 |
20100099682 | ACETYLENE DERIVATIVES - The invention provides compounds of formula (I) | 04-22-2010 |
20100137340 | FUSED PYRIMIDINONE COMPOUNDS AS MGLUR LIGANDS - The invention relates to compounds of Formula (I) wherein the substituents are as defined in claim | 06-03-2010 |
20120309742 | USE OF METABOTROPIC GLUTAMATE RECEPTORS - The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction. | 12-06-2012 |
20140187600 | USE OF METABOTROPIC GLUTAMATE RECEPTORS - The invention concerns the use an mGluR modulator, e.g. an mGluR5 modulator, for the treatment, prevention or delay of progression of cognitive dysfunction. | 07-03-2014 |